Newbridge Financial Services Group, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,167
-0.9%
334
+0.6%
0.00%0.0%
Q2 2023$5,212
-4.7%
3320.0%0.00%0.0%
Q1 2023$5,467
+5.6%
3320.0%0.00%0.0%
Q4 2022$5,175
+29.4%
332
+0.9%
0.00%
+50.0%
Q3 2022$4,000
-20.0%
329
+0.6%
0.00%
-33.3%
Q2 2022$5,0000.0%3270.0%0.00%
+50.0%
Q1 2022$5,000
+25.0%
3270.0%0.00%0.0%
Q4 2021$4,000
+100.0%
327
+149.6%
0.00%
+100.0%
Q3 2021$2,0000.0%131
+2.3%
0.00%0.0%
Q2 2021$2,0000.0%1280.0%0.00%0.0%
Q1 2021$2,0001280.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders